International Psoriasis Council

A new IPC paper published in #JAADjournals presents five priorities for improving metabolic screening, advancing GLP-1 research, and defining the dermatologist's role in coordinating cardiometabolic care for #psoriasis patients. psoriasiscouncil.org/ipc-publicatio… #MetabolicHealth

August is #PsAActionMonth. In this Take Ten with IPC, #IPCCouncilor Anna López Ferrer, MD, PhD, presents PURE-4, a validated 4-item questionnaire that flags psoriasis patients who need closer monitoring or rheumatology referral. psoriasiscouncil.org/resources/pure… #PsoriaticArthritis

📰 The July edition of the IPC Psoriasis Review is here! More than 12,000 dermatologists and health care professionals rely on IPC for updates on psoriasis research, education, and clinical care. Read the July issue now: mailchi.mp/psoriasiscounc… #PsoriasisNews #Psoriasis

🔁 A new study in the 𝐽𝑜𝑢𝑟𝑛𝑎𝑙 𝑜𝑓 𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑀𝑒𝑑𝑖𝑐𝑖𝑛𝑒 identifies a genetic subtype of #psoriasis that doesn't run on the IL-17/IL-23 pathway most current treatments target. Read our full breakdown: psoriasiscouncil.org/research/a-new… #PsoriasisGenetics #ADAR1

A therapeutic gap has long existed between oral systemics and biologics for psoriasis. #IPCCouncilor Dr. Jason Hawkes breaks down the first oral peptide and where it fits, in From Bench to Bedside. scholarsinmedicine.com/limited-series… #Psoriasis

🇦🇹 IPC will be at #EADV! Two patients, same PASI score, completely different responses to treatment. Why? At Last! Personalized Medicine for #Psoriasis, our symposium at #EADV2026, takes on that question directly. Join us on Sept 30 | 08:30–10:00 CEST: psoriasiscouncil.org/event-post/ead…

🔁 #IPCCouncilor Dr. Helen Young breaks down a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of disease progression, and what the CD200–CD200R1 axis could mean for preventing psoriatic arthritis. psoriasiscouncil.org/commentaries/p… #Psoriasis

#IPCCouncilor Alex Tsoi uses gene expression data in a new video to break down what controlled inflammation actually means, what limits it, and how it connects comorbidities like type 2 diabetes and multiple sclerosis. Watch: psoriasiscouncil.org/resources/cont… #Psoriasis #Comorbidities

IPC & @CouncilEczema are co-hosting the Eczema and Psoriasis Research Incubator at #ESDR2026. Travel scholarships are available! Apply today: psoriasiscouncil.org/event-post/esd… Thank you to @LEOFondet & @TakedaPharma for supporting this program. #Psoriasis #Eczema #SkinResearch

#IPCJrCouncilors launched a new Leadership Development series, starting with a session on time management for dermatology leaders. #IPCCouncilor Dr. Melinda Gooderham shared strategies for balancing clinical work, research, and leadership, followed by Q&A. More sessions to come!

🇦🇹 IPC is heading to Vienna! At #EADV2026, our symposium takes on one of the most common questions in clinic: why do two patients with the same PASI score respond so differently to treatment? View the agenda and register: psoriasiscouncil.org/event-post/ead… #Psoriasis #PsoriasisEvent

🔁 2026 #IPCFellow Dr. Yemsrach Abawaji shares what she sees firsthand in Addis Ababa, Ethiopia: years-long misdiagnoses, no access to biologics, and a teledermatology workaround her team built to reach rural patients. Read her full perspective: psoriasiscouncil.org/comorbidities/…

In Episode 1 of this new limited series from Scholars in Medicine, #IPCPresident Dr. Bruce Strober and #IPCBoard Member Dr. Andrew Blauvelt discuss why complete skin clearance should be the goal clinicians and patients aim for. scholarsinmedicine.com/limited-series… #Psoriasis #Dermatology

📰 ICYMI: The June issue of the IPC Psoriasis Review is now available, featuring: Join 12,000+ professionals staying informed with monthly updates on psoriasis news, research, and education. Read the June issue now: mailchi.mp/psoriasiscounc… #PsoriasisNews #IPCNews #Psoriasis

In this video, #IPCCouncilor Wilson Liao breaks down clinical escape in #psoriasis, covering paradoxical reactions, immune switching, and how these responses compare to conventional psoriasis, along with the adaptive immune pathways involved: psoriasiscouncil.org/resources/clin… #Biologics

New research from @PsoriasisIFPA: comorbidities like cardiovascular disease, diabetes, and depression drive $5.2 billion in annual US healthcare costs, reaching $153 billion over a lifetime. Earlier treatment could cut costs 34%-48%. Read the study: ifpa-pso.com/resources-tool…

@ILDSDerm maintains a collection of 35 member journals from dermatological societies around the world, covering clinical research, treatment advances, and public health topics in dermatology. ilds.org/membership/mem… #Dermatology #Psoriasis #DermatologyResource

Sept. 9 at #ESDR2026: @CouncilEczema and IPC launch the IEC-IPC #Eczema & #Psoriasis Research Incubator. Keynotes on disease endotypes, then Challenge Labs pairing junior and senior researchers. Support in part by: @LEOFondet, @TakedaPharma. Apply today: psoriasiscouncil.org/event-post/esd…

A new study in the 𝐽𝑜𝑢𝑟𝑛𝑎𝑙 𝑜𝑓 𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑀𝑒𝑑𝑖𝑐𝑖𝑛𝑒 identifies a genetic subtype of #psoriasis that doesn't run on the IL-17/IL-23 pathway most current treatments target. Read our full breakdown: psoriasiscouncil.org/research/a-new… #PsoriasisGenetics #ADAR1

The IPC Diverse Skin Image Gallery documents plaque color, scale, & morphology across skin tones. We're seeking images showing post-inflammatory hyper- and hypopigmentation, changes more common in darker skin. Supported in part by Takeda and LEO. Submit: psoriasiscouncil.org/ipc-resources/…